Persantine Aspirin Trial

Completed

Phase N/A Results

Summary of Purpose

To test the relative efficacies of aspirin and dipyridamole in the reduction of cerebral and retinal infarction or death in patients with a history of TIA.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Boehringer-Ingelheim

Trial Design

Double-blind, randomized, cooperative trial of 890 patients at 15 centers in the U.S. and Canada.

Contacts

Not available